209 related articles for article (PubMed ID: 29438157)
21. Effect of Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Among Smokers Who Drink Heavily: A Randomized Clinical Trial.
King A; Vena A; de Wit H; Grant JE; Cao D
JAMA Netw Open; 2022 Mar; 5(3):e220951. PubMed ID: 35244704
[TBL] [Abstract][Full Text] [Related]
22. Moderators of Varenicline Treatment Effects in a Double-Blind, Placebo-Controlled Trial for Alcohol Dependence: An Exploratory Analysis.
Falk DE; Castle IJ; Ryan M; Fertig J; Litten RZ
J Addict Med; 2015; 9(4):296-303. PubMed ID: 26083958
[TBL] [Abstract][Full Text] [Related]
23. Varenicline decreases alcohol consumption in heavy-drinking smokers.
Mitchell JM; Teague CH; Kayser AS; Bartlett SE; Fields HL
Psychopharmacology (Berl); 2012 Oct; 223(3):299-306. PubMed ID: 22547331
[TBL] [Abstract][Full Text] [Related]
24. Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.
Miranda R; O'Malley SS; Treloar Padovano H; Wu R; Falk DE; Ryan ML; Fertig JB; Chun TH; Muvvala SB; Litten RZ
Alcohol Clin Exp Res; 2020 Jul; 44(7):1431-1443. PubMed ID: 32363592
[TBL] [Abstract][Full Text] [Related]
25. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women.
Gray KM; McClure EA; Baker NL; Hartwell KJ; Carpenter MJ; Saladin ME
Addiction; 2015 Jun; 110(6):1027-34. PubMed ID: 25727442
[TBL] [Abstract][Full Text] [Related]
26. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.
Anthenelli RM; Benowitz NL; West R; St Aubin L; McRae T; Lawrence D; Ascher J; Russ C; Krishen A; Evins AE
Lancet; 2016 Jun; 387(10037):2507-20. PubMed ID: 27116918
[TBL] [Abstract][Full Text] [Related]
27. Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study.
Chengappa KN; Perkins KA; Brar JS; Schlicht PJ; Turkin SR; Hetrick ML; Levine MD; George TP
J Clin Psychiatry; 2014 Jul; 75(7):765-72. PubMed ID: 25006684
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use: A Randomized Clinical Trial.
Tindle HA; Freiberg MS; Cheng DM; Gnatienko N; Blokhina E; Yaroslavtseva T; Bendiks S; Patts G; Hahn J; So-Armah K; Stein MD; Bryant K; Lioznov D; Krupitsky E; Samet JH
JAMA Netw Open; 2022 Aug; 5(8):e2225129. PubMed ID: 35930287
[TBL] [Abstract][Full Text] [Related]
29. Randomised, placebo-controlled, double-blind, double-dummy, multicentre trial comparing electronic cigarettes with nicotine to varenicline and to electronic cigarettes without nicotine: the ECSMOKE trial protocol.
Berlin I; Dautzenberg B; Lehmann B; Palmyre J; Liégey E; De Rycke Y; Tubach F
BMJ Open; 2019 May; 9(5):e028832. PubMed ID: 31129603
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers.
Nakamura M; Oshima A; Fujimoto Y; Maruyama N; Ishibashi T; Reeves KR
Clin Ther; 2007 Jun; 29(6):1040-56. PubMed ID: 17692720
[TBL] [Abstract][Full Text] [Related]
31. Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse.
Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
Addict Biol; 2019 Jul; 24(4):765-776. PubMed ID: 30378231
[TBL] [Abstract][Full Text] [Related]
32. Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial.
O'Malley SS; Zweben A; Fucito LM; Wu R; Piepmeier ME; Ockert DM; Bold KW; Petrakis I; Muvvala S; Jatlow P; Gueorguieva R
JAMA Psychiatry; 2018 Feb; 75(2):129-138. PubMed ID: 29261824
[TBL] [Abstract][Full Text] [Related]
33. Effects of varenicline on subjective craving and relative reinforcing value of cigarettes.
Green R; Ray LA
Drug Alcohol Depend; 2018 Jul; 188():53-59. PubMed ID: 29751347
[TBL] [Abstract][Full Text] [Related]
34. Association of the Sweet-Liking Phenotype and Craving for Alcohol With the Response to Naltrexone Treatment in Alcohol Dependence: A Randomized Clinical Trial.
Garbutt JC; Kampov-Polevoy AB; Kalka-Juhl LS; Gallop RJ
JAMA Psychiatry; 2016 Oct; 73(10):1056-1063. PubMed ID: 27627782
[TBL] [Abstract][Full Text] [Related]
35. Nicotine receptor partial agonists for smoking cessation.
Livingstone-Banks J; Fanshawe TR; Thomas KH; Theodoulou A; Hajizadeh A; Hartman L; Lindson N
Cochrane Database Syst Rev; 2023 May; 5(5):CD006103. PubMed ID: 37142273
[TBL] [Abstract][Full Text] [Related]
36. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
Ebbert JO; Hatsukami DK; Croghan IT; Schroeder DR; Allen SS; Hays JT; Hurt RD
JAMA; 2014 Jan; 311(2):155-63. PubMed ID: 24399554
[TBL] [Abstract][Full Text] [Related]
37. Effects of Combined Varenicline With Nicotine Patch and of Extended Treatment Duration on Smoking Cessation: A Randomized Clinical Trial.
Baker TB; Piper ME; Smith SS; Bolt DM; Stein JH; Fiore MC
JAMA; 2021 Oct; 326(15):1485-1493. PubMed ID: 34665204
[TBL] [Abstract][Full Text] [Related]
38. A Combination of Naltrexone + Varenicline Retards the Expression of a Genetic Predisposition Toward High Alcohol Drinking.
Froehlich JC; Fischer SM; Nicholson ER; Dilley JE; Filosa NJ; Smith TN; Rademacher LC
Alcohol Clin Exp Res; 2017 Mar; 41(3):644-652. PubMed ID: 28055135
[TBL] [Abstract][Full Text] [Related]
39. Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement: A Randomized Clinical Trial.
Cinciripini PM; Green CE; Shete S; Minnix JA; Robinson JD; Cui Y; Kim S; Kypriotakis G; Beneventi D; Blalock JA; Versace F; Karam-Hage M
JAMA; 2024 May; 331(20):1722-1731. PubMed ID: 38696203
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Tobacco Smoking: A Review.
Rigotti NA; Kruse GR; Livingstone-Banks J; Hartmann-Boyce J
JAMA; 2022 Feb; 327(6):566-577. PubMed ID: 35133411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
